EU Goes All-In on Novel Vaccines, Reserves Capacity for Next Pandemic
In addition to planning a new rollout of the Covid-19 vaccination campaign in the fall, the European Union is already reserving “ever warm” novel vaccine production capacity for the next public health emergency: this as part of a so-called EU FAB initiative under the aegis of the EU’s recently-created Health Emergency Preparedness and Response Authority (HERA).
The public tender was announced by the European Commission in the same April 27th documents in which it announced its intention to target the still unvaccinated and children for Covid-19 vaccination in the fall.
For the details, see my new article for the Brownstone Institute here.